Prospects of therapy for infections with human T-lymphotropic virus type III

Insights

Researchers are exploring antiviral drugs like suramin and interferon alpha to combat Human T-lymphotropic virus type III (HTLV-III) replication. Combination therapies may be key for treating acquired immunodeficiency syndrome.

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Background:

  • Human T-lymphotropic virus type III (HTLV-III) is a significant pathogen.
  • The virus has multiple targets within its replicative cycle.

Purpose of the Study:

  • To review current antiviral agents and therapeutic strategies for HTLV-III.
  • To highlight the need for controlled clinical trials in managing HTLV-III infection and acquired immunodeficiency syndrome (AIDS).

Main Methods:

  • Review of in-vitro studies and early clinical trials of antiviral agents.
  • Discussion of ongoing double-blind, placebo-controlled trials for interferon alpha.
  • Emphasis on the necessity of multicenter collaborative trials.

Main Results:

  • Several inhibitors of reverse transcriptase, including suramin, HPA-23, and trisodium phosphonoformate, show in-vitro activity.
  • Recombinant interferon alpha-A, ribavirin, and ansamycin are identified as significant antiviral agents.
  • Interferon alpha demonstrates efficacy in inhibiting viral replication at achievable serum levels.

Conclusions:

  • Optimal therapeutic regimens for HTLV-III require carefully controlled, multicenter trials.
  • Prolonged combination therapy with antiviral and immunomodulating agents may be necessary for effective HTLV-III replication control and AIDS treatment.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
2.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
828
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
360
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343